tiprankstipranks
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
US Market

Rhythm Pharmaceuticals (RYTM) Income Statement

Compare
480 Followers

Rhythm Pharmaceuticals Income Statement

Last quarter (Q3 2024), Rhythm Pharmaceuticals's total revenue was $33.25M, an increase of 47.76% from the same quarter last year. In Q3, Rhythm Pharmaceuticals's net income was $-44.97M. See Rhythm Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 77.43M$ 23.64M$ 3.15M$ 0.00$ 0.00
Gross Profit
$ 68.13M$ 21.50M$ 2.56M$ -690.00K$ -834.00K
Operating Expenses
$ 252.48M$ 200.66M$ 172.61M$ 136.57M$ 146.00M
Depreciation and Amortization
$ 1.76M$ 1.40M$ 1.16M$ 690.00K$ 834.00K
EBITDA
$ -168.46M$ -174.51M$ -68.45M$ -135.88M$ -145.17M
Operating Income
$ -184.36M$ -179.16M$ -170.06M$ -136.57M$ -146.00M
Other Income/Expenses
$ 243.00K$ -1.96M$ 100.45M$ 2.58M$ 5.27M
Pretax Income
$ -184.11M$ -181.12M$ -69.61M$ -134.00M$ -140.73M
Net Income
$ -184.68M$ -183.08M$ -68.01M$ -130.73M$ -134.62M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.20$ -3.51$ -1.37$ -2.96$ -3.70
Diluted EPS
$ -3.20$ -3.51$ -1.37$ -2.96$ -3.70
Weighted Average Shares Outstanding
57.67M 52.12M 49.60M 44.13M 36.42M
Weighted Average Shares Outstanding (Diluted)
57.67M 52.12M 49.60M 44.13M 36.42M
Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis